Global Medical Foods For Inborn Errors Of Metabolism Market
Размер рынка в млрд долларов США
CAGR : %
Прогнозируемый период |
2024 –2031 |
Размер рынка (базовый год) |
USD 2,477.81 Million |
Размер рынка (прогнозируемый год) |
USD 7,998.77 Million |
CAGR |
|
Основные игроки рынка |
|
>Глобальный рынок медицинских продуктов для врожденных нарушений метаболизма, побочные продукты (аминокислоты, продукты с низким содержанием белка, глитактин с модифицированной аминокислотой GMP детской смесью с железом, детская смесь с низким содержанием кальция/витамина D с железом и другие), заболевания (фенилкетонурия (ФКУ), рирозинемия типов I и II, болезнь кленового сиропа (БМС), гомоцистинурия, глутаровая ацидемия типа I, нарушения цикла мочевины, метилмалоновая ацидемия, изовалериановая ацидемия, органические ацидурии, заболевания почек, пропионовая ацидемия, нарушения метаболизма лейцина и другие), возрастная группа (младенцы, отлучение от груди, подростки и взрослые), формы (порошок, жидкость, таблетки, гели и другие), упаковка (банки, пакеты, бутылки и другие), канал распространения (розничная торговля) Аптека, больничная аптека, интернет-аптека, аптечный магазин и другие) — тенденции отрасли и прогноз до 2031 года.
Анализ и размер рынка медицинских продуктов питания для лечения врожденных нарушений обмена веществ
Ожидается , что рост числа случаев врожденных нарушений метаболизма (IEM) и предпочтение диетических добавок ферментозаместительной терапии (ERT) будут способствовать росту рынка. Отсутствие возможностей возмещения расходов на эти медицинские продукты питания, а также их высокая стоимость, потенциально сдерживают рост рынка.
По данным исследования рынка Data Bridge, ожидается, что мировой рынок медицинских продуктов питания для лечения врожденных нарушений обмена веществ будет расти со среднегодовым темпом роста 14,1% в прогнозируемый период с 2023 по 2031 год и достигнет 7 998,77 млн долларов США к 2031 году по сравнению с 2 477,81 млн долларов США в 2023 году.
Отчет о мировом рынке медицинских продуктов для врожденных ошибок метаболизма содержит подробную информацию о доле рынка, новых разработках и влиянии отечественных и локальных игроков рынка, анализирует возможности с точки зрения новых источников дохода, изменений в рыночных правилах, одобрений продуктов, стратегических решений, запусков продуктов, географических расширений и технологических инноваций на рынке. Чтобы понять анализ и рыночный сценарий, свяжитесь с нами для получения аналитического брифинга. Наша команда поможет вам создать решение, влияющее на доход, для достижения желаемой цели.
Отчет Метрика |
Подробности |
Прогнозируемый период |
2023-2031 |
Базовый год |
2022 |
Исторические годы |
2021 (можно настроить на 2015-2020) |
Количественные единицы |
Доход в млн. долл. США |
Охваченные сегменты |
Продукты (аминокислоты, низкобелковая пища, глитактин с модифицированной аминокислотой GMP детской смесью с железом, низкокальциевая/без витамина D детская смесь с железом и другие), заболевания ( фенилкетонурия (ФКУ), рирозинемия типов I и II, болезнь кленового сиропа мочи (MSUD), гомоцистинурия, глутаровая ацидемия типа I, нарушения цикла мочевины, метилмалоновая ацидемия , изовалериановая ацидемия, органические ацидурии, заболевания почек, пропионовая ацидемия, нарушения метаболизма лейцина и другие), возрастная группа (младенцы, отлучение от груди, подростки и взрослые), формы (порошок, жидкость, таблетки, гели и другие), упаковка (банка, пакет, бутылка и другие), канал сбыта (розничная аптека, больничная аптека, интернет-аптека, аптека и Другие) |
Страны, охваченные |
США, Канада, Мексика, Германия, Франция, Великобритания, Италия, Испания, Россия, Турция, Бельгия, Нидерланды, Швейцария, Польша, Финляндия, Дания, Швеция, Норвегия, остальная Европа, Япония, Китай, Индия, Южная Корея, Австралия, Сингапур, Таиланд, Малайзия, Индонезия, Новая Зеландия, Вьетнам, Филиппины, Тайвань, остальная часть Азиатско-Тихоокеанского региона Бразилия, Аргентина, остальная часть Южной Америки, Южная Африка, Саудовская Аравия, Бахрейн, ОАЭ, Кувейт, Катар, Египет, Оман и остальная часть Ближнего Востока и Африки |
Охваченные участники рынка |
Nutricia, Abbott, Baxter, Nestlé Health Science, Meiji Holdings Co., Ltd., Hexagon Nutrition Ltd, Kate Farms, Primus Pharmaceuticals, Inc., Promin, Ajinomoto Cambrooke, Inc., Galen Limited, Piam Farmaceutici SPA, Orpharma Pty Ltd., PKU-Mdmil.com, B. Braun SE, Pristine Organics Pvt Ltd., Mead Johnson & Company, LLC., EBM Medical, Biovencer Healthcare Pvt Ltd и Solace Nutrition и другие. |
Определение рынка
Врожденные нарушения метаболизма (ВНМ) — это группа расстройств, при которых организм не может преобразовывать пищу в энергию. Из-за мутаций в генах снижается или отсутствует выработка определенных ферментов, которые отвечают за расщепление определенных веществ. Это расщепление приводит к накоплению некоторых токсичных веществ и вызывает серьезные осложнения. Для лечения этих расстройств пациентам назначают специальные диеты, которые также известны как лечебное питание под наблюдением врачей. Например, фенилкетонурия (ФКУ) — это заболевание, при котором происходит накопление аминокислоты, известной как фенилаланин. Это может привести к умственной отсталости, судорогам и многим другим психическим расстройствам. Для лечения этого заболевания им назначают диеты ВНМ, такие как Фенилкетонурия (ФКУ)-1, производимые Pristine Organics Pvt Ltd.
Динамика мирового рынка медицинских продуктов питания для лечения врожденных нарушений обмена веществ
Драйверы
- Рост случаев врожденных нарушений обмена веществ (ВНМ)
Расширенные методы диагностики играют важную роль в растущем принятии IEM. В прошлом эти расстройства часто неправильно диагностировались или игнорировались из-за ограниченной информации и диагностических инструментов. Однако достижения в области медицинских технологий и генетического тестирования изменили нашу способность точно диагностировать IEM. Расширенные технологии, такие как секвенирование следующего поколения и биохимический анализ, позволяют медицинским работникам выявлять определенные генетические мутации или аномалии в метаболических путях, связанных с этими расстройствами. Эта улучшенная диагностическая точность способствовала увеличению заболеваемости IEM. Например, достижения в технологии секвенирования следующего поколения позволили выявить редкие варианты IEM, которые ранее было трудно обнаружить. Это позволило проводить более точную и всестороннюю диагностику этих расстройств.
- Растущее предпочтение диетическим добавкам по сравнению с ферментозаместительной терапией (ФЗТ)
Растущее предпочтение диетических добавок по сравнению с ферментозаместительной терапией (ФЗТ) при лечении ИЭМ может быть обусловлено несколькими факторами. Во-первых, диетические добавки предлагают неинвазивный и удобный подход к лечению. В отличие от ФЗТ, которая часто включает инъекцию или инфузию, добавки можно принимать перорально, что делает их более привлекательными для пациентов, которые хотят менее инвазивный вариант. Кроме того, пищевые добавки обеспечивают комплексную питательную поддержку, поскольку они содержат различные питательные вещества, кофакторы и субстраты, необходимые для оптимального метаболизма. Этот более широкий спектр поддержки устраняет несколько метаболических дефицитов, связанных с определенными ИЭМ, что может привести к более эффективному лечению этого состояния.
Возросшая популярность пищевых добавок привела к росту спроса на специализированные медицинские продукты питания, которые отвечают уникальным потребностям в питании пациентов с IEM. Это расширило размер рынка и побудило производителей разработать более широкий ассортимент продуктов для удовлетворения этого спроса. Кроме того, предпочтение диетическим добавкам стимулировало НИОКР по улучшению состава и эффективности медицинских продуктов питания, что привело к использованию новых и лучших альтернатив. Таким образом, ожидается, что растущее предпочтение диетическим добавкам по сравнению с ЗТЭ при лечении IEM будет способствовать росту рынка.
Возможности
- Правительственные инициативы и программы по повышению осведомленности о врожденных нарушениях метаболизма
Правительства по всему миру признали важность повышения осведомленности о IEM и внедрили различные инициативы и программы для решения этой проблемы. Эти инициативы направлены на просвещение медицинских работников, отдельных лиц и семей, затронутых IEM, и широкой общественности. Вот некоторые правительственные инициативы и программы по повышению осведомленности о IEM. Правительственные инициативы и программы, направленные на повышение осведомленности о IEM, выступают в качестве рыночных возможностей, стимулируя спрос на диагностические инструменты, терапевтические процедуры и специализированные продукты. Эти инициативы также содействуют НИОКР, способствуют расширению рынка за счет международного сотрудничества и предоставляют финансирование и поддержку компаниям в этой области. Таким образом, правительственные инициативы и программы по повышению осведомленности о IEM, как ожидается, предоставят возможность для роста рынка.
Сдержанность/Вызов
- Высокая стоимость лечебного питания
Высокая стоимость лечебного питания обусловлена многими факторами, которые влияют на стоимость его производства, разработки и распространения. Во-первых, специальные лечебные продукты требуют обширных НИОКР. Производители инвестируют в научные исследования и клинические испытания, чтобы найти оптимальное сочетание питательных веществ, биоактивных соединений и терапевтических агентов для лечения определенных заболеваний. Это исследование включает экспертизу диетологов и специалистов в области здравоохранения, что увеличивает общую стоимость. Высокая стоимость лечебного питания является рыночным ограничением, поскольку она ограничивает доступность и охват рынка. Высокие ценники делают эти специальные пищевые продукты недоступными для многих людей. Таким образом, ожидается, что высокая стоимость лечебного питания будет сдерживать рост рынка.
Последние события
- В октябре 2023 года Nestlé Health Science и Amwell объявили о сотрудничестве, которое поможет организациям здравоохранения улучшить общее состояние здоровья пациентов с помощью инновационных цифровых решений, ориентированных на питание. Вместе компании разрабатывают портфель новых решений, которые помогут улучшить клинические и финансовые результаты. Это улучшит имидж обеих компаний
- В марте 2021 года компания Meiji Co., Ltd. запустила молочную смесь в формате таблеток под брендом Aptamil компании Danone в Великобритании. Таблетки с предварительно отмеренными вкладками призваны обеспечить удобство для родителей. Производство началось в Уэксфорде, Ирландия, объединив технологию Meiji с рецептами Danone. Danone планирует расширить продукт на другие европейские страны, начиная с 2022 года. Meiji стремится увеличить зарубежные продажи до 10% к 2026 финансовому году
Глобальный рынок медицинских продуктов питания для лечения врожденных нарушений обмена веществ
Глобальный рынок медицинских продуктов для врожденных нарушений метаболизма сегментирован на шесть заметных сегментов на основе продуктов, заболеваний, возрастной группы, форм, упаковки и канала сбыта. Рост среди этих сегментов поможет вам проанализировать основные сегменты роста в отраслях и предоставить пользователям ценный обзор рынка и рыночные идеи для принятия стратегических решений по определению основных рыночных приложений.
Продукция
- Аминокислота
- Пища с низким содержанием белка
- Глитактин с модифицированной аминокислотой GMP детской смесью с железом
- Детская смесь с низким содержанием кальция и витамина D, с железом
- Другие
По видам продукции мировой рынок лечебного питания для лечения врожденных нарушений обмена веществ сегментируется на аминокислоты, глитактин с модифицированными аминокислотами GMP, детские смеси с железом, детские смеси с низким содержанием кальция и витамина D, но без железа, продукты с низким содержанием белка и другие.
Заболевания
- Фенилкетонурия (ФКУ)
- Тирозинемия типов I и II
- Болезнь мочи с запахом кленового сиропа (БМС)
- Гомоцистинурия
- Глутаровая ацидемия I типа
- Нарушения цикла мочевины
- Метилмалоновая ацидемия
- Изовалериановая ацидемия
- Органические ацидурии
- Заболевание почек
- Пропионовая ацидемия
- Нарушения метаболизма лейцина
- Другие
На основе заболеваний глобальный рынок лекарственных продуктов для лечения врожденных нарушений обмена веществ сегментируется на следующие заболевания: фенилкетонурия (ФКУ), тирозинемия I и II типов, болезнь кленового сиропа (БМС), гомоцистинурия, глутаровая ацидемия I типа, нарушения цикла мочевины, метилмалоновая ацидемия, изовалериановая ацидемия, органические ацидурии, заболевания почек, пропионовая ацидемия, нарушения обмена лейцина и другие.
Возрастная группа
- Младенцы
- Отлучения от груди
- Подросток
- Взрослые
По возрастному признаку мировой рынок лечебных продуктов питания для лечения врожденных нарушений обмена веществ сегментируется на младенцев, детей, находящихся на грудном вскармливании, подростков и взрослых.
Формы
- Пудра
- Жидкость
- Таблетки
- Гели
- Другие
По форме мировой рынок лечебных продуктов питания для лечения врожденных нарушений обмена веществ сегментируется на порошки, жидкости, таблетки, гели и другие.
Упаковка
- Может
- Пакеты
- Бутылка
- Банка
- Другие
По типу упаковки мировой рынок лечебных продуктов для лечения врожденных нарушений обмена веществ сегментируется на банки, стеклянные банки, пакеты, бутылки и другие.
Канал распространения
- Больничная аптека
- Розничная аптека
- Аптеки
- Интернет-аптека
- Другие
На основе каналов сбыта мировой рынок лекарственных продуктов для лечения врожденных нарушений обмена веществ сегментируется на розничные аптеки, больничные аптеки, интернет-аптеки, аптечные магазины и другие.
Региональный анализ/информация о мировом рынке медицинских продуктов питания для лечения врожденных нарушений обмена веществ
Мировой рынок медицинских продуктов питания для лечения врожденных нарушений обмена веществ разделен на шесть основных сегментов в зависимости от продуктов, заболеваний, возрастной группы, формы, упаковки и канала сбыта.
Страны на мировом рынке медицинских продуктов питания для лечения врожденных нарушений обмена веществ: США, Канада, Мексика, Германия, Франция, Великобритания, Италия, Испания, Россия, Турция, Бельгия, Нидерланды, Швейцария, Польша, Финляндия, Дания, Швеция, Норвегия, остальные страны Европы, Япония, Китай, Индия, Южная Корея, Австралия, Сингапур, Таиланд, Малайзия, Индонезия, Новая Зеландия, Вьетнам, Филиппины, Тайвань, остальные страны Азиатско-Тихоокеанского региона, Бразилия, Аргентина, остальные страны Южной Америки, Южная Африка, Саудовская Аравия, Бахрейн, ОАЭ, Кувейт, Катар, Египет, Оман и остальные страны Ближнего Востока и Африки.
Ожидается, что Северная Америка будет доминировать на мировом рынке медицинских продуктов питания для врожденных нарушений обмена веществ из-за своей передовой инфраструктуры здравоохранения, интенсивных исследовательских усилий, строгого надзора со стороны регулирующих органов, повышенной осведомленности общественности об этих состояниях, широкого доступа к комплексному страховому покрытию и проактивной государственной политики. Ожидается, что США будут доминировать в регионе Северной Америки из-за производителей, предлагающих инновационные решения для лечения редких генетических заболеваний, и, следовательно, в этом регионе генерируется большой доход. Ожидается, что Китай будет доминировать в Азиатско-Тихоокеанском регионе из-за своего конкурентного преимущества в эффективности производства и экономической эффективности. Ожидается, что Германия будет доминировать в регионе Европы, поскольку производители выпускают на этот рынок множество усовершенствованных и передовых продуктов.
Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании рынка, которые влияют на текущие и будущие тенденции рынка. Анализ цепочек создания стоимости по точкам данных вниз и вверх по течению, анализ пяти сил Портера технических тенденций и тематические исследования — вот некоторые из указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по странам учитываются наличие и доступность глобальных брендов и их проблемы, связанные с большой или малой конкуренцией со стороны местных и отечественных брендов, влияние внутренних тарифов и торговые пути.
Конкурентная среда и глобальный анализ доли рынка медицинских продуктов для лечения врожденных нарушений обмена веществ
Глобальный рынок медицинских продуктов для врожденных ошибок метаболизма конкурентный ландшафт содержит данные по конкурентам. Включены сведения о компании, финансы компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, производственные площадки и объекты, сильные и слабые стороны компании, запуск продукта, конвейеры испытаний продукта, одобрения продукта, патенты, ширина продукта и широта, доминирование приложений, кривая жизненной линии технологии. Приведенные выше точки данных связаны только с фокусом компаний, связанным с глобальным рынком медицинских продуктов для врожденных ошибок метаболизма.
Некоторые из видных участников мирового рынка медицинских продуктов питания для лечения врожденных нарушений обмена веществ включают Nutricia, Abbott, Baxter, Nestlé Health Science, Meiji Holdings Co., Ltd., Hexagon Nutrition Ltd, Kate Farms, Primus Pharmaceuticals, inc., Promin, Ajinomoto Cambrooke, Inc., Galen Limited, Piam Farmaceutici SPA, Orpharma Pty Ltd., PKU-Mdmil.com, B. Braun SE, Pristine Organics Pvt Ltd., Mead Johnson & Company, LLC., EBM Medical, Biovencer Healthcare Pvt Ltd и Solace Nutrition и другие.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 DBMR MARKET POSITION GRID
2.8 SECONDARY SOURCES
2.9 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 EPIDEMIOLOGY
4.1.1 PREVALENCE OF INBORN ERRORS OF METABOLISM
4.1.2 NEW-BORN SCREENING PROGRAMS
4.1.3 GENETIC HETEROGENEITY
4.1.4 IMPACT ON HEALTH
4.1.5 CLINICAL IMPAC
4.1.6 TREATMENT AND MANAGEMENT
4.2 PESTLE ANALYSIS
4.2.1 POLITICAL FACTORS
4.2.2 ECONOMIC FACTORS
4.2.3 SOCIAL FACTORS
4.2.4 TECHNOLOGICAL FACTORS
4.2.5 ENVIRONMENTAL FACTORS
4.2.6 LEGAL FACTORS
4.3 PORTER’S FIVE FORCES
4.3.1 THREAT OF NEW ENTRANTS
4.3.2 THREAT OF SUBSTITUTES
4.3.3 BARGAINING POWER OF BUYERS
4.3.4 BARGAINING POWER OF SUPPLIERS
4.3.5 COMPETITIVE RIVALRY
4.4 INDUSTRY INSIGHTS
4.4.1 DEMOGRAPHIC TRENDS
4.4.2 KEY PRICING STRATEGIES
4.4.3 KEY PATIENT ENROLLMENT STRATEGIES
4.5 PATENT ANALYSIS
4.6 PIPELINE ANALYSIS
4.6.1 RESEARCH AND DEVELOPMENT
4.6.2 CLINICAL TRIALS
4.6.3 REGULATORY APPROVAL
4.6.4 MANUFACTURING AND PRODUCTION
4.6.5 COMMERCIALIZATION AND MARKET ACCESS
4.6.6 DISTRIBUTION AND SUPPLY CHAIN MANAGEMENT
4.6.7 POST-MARKET SURVEILLANCE AND MONITORING
4.7 REGULATION COVERAGE
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING INCIDENCES OF INBORN ERRORS OF METABOLISM (IEM)
5.1.2 RISING PREFERENCE FOR DIETARY SUPPLEMENTS OVER ENZYME REPLACEMENT THERAPY (ERT)
5.1.3 INCREASE IN THE NUMBER OF NEW-BORN SCREENING PROCEDURES
5.1.4 INCREASING SPENDING ON MEDICAL FOOD PRODUCTS
5.2 RESTRAINTS
5.2.1 HIGH COST OF MEDICAL FOODS
5.2.2 STRINGENT REGULATIONS FOR MEDICAL FOODS
5.3 OPPORTUNITIES
5.3.1 GOVERNMENT INITIATIVES AND PROGRAMS FOR CREATING AWARENESS ABOUT INBORN ERRORS OF METABOLISM
5.3.2 INCREASING COLLABORATIONS AND PARTNERSHIPS IN THE MARKET
5.3.3 EXPANSION OF MEDICAL FOODS IN EMERGING MARKETS
5.4 CHALLENGES
5.4.1 POOR ACCESSIBILITY OF MEDICAL FOODS
5.4.2 ALTERNATIVE TREATMENT APPROACHES FOR INBORN ERRORS OF METABOLISM
6 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS
6.1 OVERVIEW
6.2 AMINO ACID
6.2.1 AMINO ACID, BY PRODUCTS
6.2.1.1 amino acid mixtures, BY products
6.2.1.2 phenylade, BY products
6.2.1.1 single amino acids, BY products
6.3 LOW PROTEIN FOOD
6.3.1 LOW PROTEIN FOOD, BY PRODUCTS
6.4 GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON
6.4.1 GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON, BY FLAVORS
6.4.2 GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON, BY USAGES
6.5 LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON
6.5.1 LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON, BY PRODUCTS
6.6 OTHERS
7 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES
7.1 OVERVIEW
7.2 PHENYLKETONURIA (PKU)
7.2.1 PHENYLKETONURIA (PKU), BY DISEASES
7.3 TYROSINEMIA TYPES I AND II
7.4 MAPLE SYRUP URINE DISEASE (MSUD)
7.4.1 MAPLE SYRUP URINE DISEASE (MSUD), BY DISEASES
7.5 HOMOCYSTINURIA
7.5.1 GLUTARIC ACIDEMIA TYPE I
7.6 UREA CYCLE DISORDERS
7.6.1 UREA CYCLE DISORDERS, BY DISEASES
7.7 METHYLMALONIC ACIDEMIA
7.7.1 ISOVALERIC ACIDEMIA
7.8 ORGANIC ACIDURIAS
7.9 RENAL DISEASE
7.1 PROPIONIC ACIDEMIA
7.11 DISORDERS OF LEUCINE METABOLISM
7.12 OTHERS
8 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP
8.1 OVERVIEW
8.2 INFANTS
8.3 WEANING
8.4 ADOLESCENT
8.5 ADULTS
9 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS
9.1 OVERVIEW
9.2 POWDER
9.3 LIQUID
9.4 TABLETS
9.5 GELS
9.6 OTHERS
10 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING
10.1 OVERVIEW
10.2 CAN
10.3 PACKETS
10.4 BOTTLE
10.5 JAR
10.6 OTHERS
11 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 HOSPITAL PHARMACY
11.3 RETAIL PHARMACY
11.4 DRUG STORES
11.5 ONLINE PHARMACY
11.6 OTHERS
12 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION
12.1 OVERVIEW
12.2 NORTH AMERICA
12.2.1 U S
12.2.2 CANADA
12.2.3 MEXICO
12.3 EUROPE
12.3.1 GERMANY
12.3.2 FRANCE
12.3.3 U K
12.3.4 ITALY
12.3.5 SPAIN
12.3.6 SWITZERLAND
12.3.7 NETHERLAND
12.3.8 BELGIUM
12.3.9 DENMARK
12.3.10 RUSSIA
12.3.11 SWEDEN
12.3.12 TURKEY
12.3.13 POLAND
12.3.14 FINLAND
12.3.15 REST OF EUROPE
12.4 ASIA-PACIFIC
12.4.1 CHINA
12.4.2 JAPAN
12.4.3 INDIA
12.4.4 AUSTRALIA
12.4.5 SOUTH KOREA
12.4.6 THAILAND
12.4.7 SINGAPORE
12.4.8 INDONESIA
12.4.9 MALASIA
12.4.10 NEW ZEALAND
12.4.11 VIETNAM
12.4.12 PHILIPPINES
12.4.13 TAIWAN
12.4.14 REST OF ASIA-PACIFIC
12.5 SOUTH AMERICA
12.5.1 BRAZIL
12.5.2 ARGENTINA
12.5.3 REST OF SOUTH AMERICA
12.6 MIDDLE EAST AND AFRICA
12.6.1 SOUTH AFRICA
12.6.2 SAUDI ARABIA
12.6.3 BAHRAIN
12.6.4 UNITED ARAB EMIRATES
12.6.5 KUWAIT
12.6.6 QATAR
12.6.7 EGYPT
12.6.8 OMAN
12.6.9 REST OF MIDDLE EAST AND AFRICA
13 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3 COMPANY SHARE ANALYSIS: EUROPE
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 ABBOTT
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 NESTLÉ HEALTH SCIENCE (A SUBSIDIARY OF NESTLÉ)
15.2.1 COMPANY SNAPSHOT
15.2.2 COMPANY SHARE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENTS
15.3 MEIJI HOLDINGS CO., LTD.
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 BAXTER
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 PRISTINE ORGANICS PVT LTD.
15.5.1 COMPANY SNAPSHOT
15.5.2 COMPANY SHARE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 AJINOMOTO CAMBROOKE, INC. (A SUBSIDIARY OF AJINOMOTO CO., INC.)
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 B.BRAUN SE
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 BIOVENCER HEALTHCARE PVT LTD
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 EBM MEDICAL
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 GALEN LIMITED
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 HEXAGON NUTRITION LTD.
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 KATE FARMS
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 MEAD JOHNSON & COMPANY, LLC. (A SUBSIDIARY OF RECKITT BENCKISER GROUP PLC.)
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 NUTRICIA (A SUBSIDIARY OF DANONE)
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 ORPHARMA PTY LTD.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 PIAM FARMACEUTICI S.P.A
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 PKU-MDMIL
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 PRIMUS PHARMACEUTICALS, INC.
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 PROMIN
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.2 SOLACE NUTRITION
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
Список таблиц
TABLE 1 COSTS OF MEDICAL FOODS USED IN INBORN ERRORS OF METABOLISM (IEMS)
TABLE 2 PATENT ANALYSIS
TABLE 3 REGULATORY COVERAGE
TABLE 4 COSTS OF MEDICAL FOODS
TABLE 5 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 6 GLOBAL AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 7 GLOBAL AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 8 GLOBAL AMINO ACIDS MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 9 GLOBAL PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 10 GLOBAL SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 11 GLOBAL LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 12 GLOBAL LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 13 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 14 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 15 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 16 GLOBAL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 17 GLOBAL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 18 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 19 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 20 GLOBAL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 21 GLOBAL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 22 GLOBAL TYROSINEMIA TYPES I AND II IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 23 GLOBAL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 24 GLOBAL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 25 GLOBAL HOMOCYSTINURIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 26 GLOBAL GLUTARIC ACIDEMIA TYPE I IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 27 GLOBAL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 28 GLOBAL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 29 GLOBAL METHYLMALONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 30 GLOBAL ISOVALERIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 31 GLOBAL ORGANIC ACIDURIAS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 32 GLOBAL RENAL DISEASE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 33 GLOBAL PROPIONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 34 GLOBAL DISORDERS OF LEUCINE METABOLISM IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 35 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 36 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 37 GLOBAL INFANTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 38 GLOBAL WEANING IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 39 GLOBAL ADOLESCENT IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 40 GLOBAL ADULTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 41 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 42 GLOBAL POWDER IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 43 GLOBAL LIQUID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 44 GLOBAL TABLETS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 45 GLOBAL GELS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 46 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 47 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 48 GLOBAL CAN IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 49 GLOBAL LIQUID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 50 GLOBAL BOTTLE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 51 GLOBAL JAR IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 52 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 53 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 54 GLOBAL HOSPITAL PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 55 GLOBAL RETAIL PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 56 GLOBAL DRUG STORES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 57 GLOBAL ONLINE PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 58 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 59 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 60 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031 (USD THOUSAND)
TABLE 61 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 62 NORTH AMERICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 63 NORTH AMERICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 64 NORTH AMERICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 65 NORTH AMERICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 66 NORTH AMERICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 67 NORTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 68 NORTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 69 NORTH AMERICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 70 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 71 NORTH AMERICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 72 NORTH AMERICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 73 NORTH AMERICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 74 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 75 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 76 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 77 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 78 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 79 U.S. AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 80 U.S. AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 81 U.S. PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 82 U.S. SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 83 U.S. LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 84 U.S. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 85 U.S. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 86 U.S. LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 87 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 88 U.S. PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 89 U.S. MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 90 U.S. UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 91 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 92 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 93 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 94 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 95 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 96 CANADA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 97 CANADA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 98 CANADA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 99 CANADA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 100 CANADA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 101 CANADA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 102 CANADA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 103 CANADA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 104 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 105 CANADA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 106 CANADA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 107 CANADA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 108 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 109 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 110 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 111 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 112 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 113 MEXICO AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 114 MEXICO AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 115 MEXICO PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 116 MEXICO SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 117 MEXICO LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 118 MEXICO GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 119 MEXICO GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 120 MEXICO LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 121 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 122 MEXICO PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 123 MEXICO MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 124 MEXICO UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 125 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 126 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 127 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 128 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 129 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031 (USD THOUSAND)
TABLE 130 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 131 EUROPE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 132 EUROPE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 133 EUROPE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 134 EUROPE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 135 EUROPE LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 136 EUROPE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 137 EUROPE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 138 EUROPE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 139 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 140 EUROPE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 141 EUROPE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 142 EUROPE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 143 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 144 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 145 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 146 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 147 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 148 GERMANY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 149 GERMANY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 150 GERMANY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 151 GERMANY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 152 GERMANY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 153 GERMANY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 154 GERMANY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 155 GERMANY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 156 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 157 GERMANY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 158 GERMANY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 159 GERMANY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 160 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 161 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 162 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 163 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 164 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 165 FRANCE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 166 FRANCE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 167 FRANCE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 168 FRANCE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 169 FRANCE LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 170 FRANCE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 171 FRANCE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 172 FRANCE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 173 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 174 FRANCE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 175 FRANCE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 176 FRANCE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 177 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 178 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 179 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 180 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 181 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 182 U.K. AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 183 U.K. AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 184 U.K. PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 185 U.K. SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 186 U.K. LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 187 U.K. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 188 U.K. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 189 U.K. LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 190 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 191 U.K. PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 192 U.K. MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 193 U.K. UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 194 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 195 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 196 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 197 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 198 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 199 ITALY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 200 ITALY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 201 ITALY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 202 ITALY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 203 ITALY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 204 ITALY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 205 ITALY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 206 ITALY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 207 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 208 ITALY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 209 ITALY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 210 ITALY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 211 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 212 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 213 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 214 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 215 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 216 SPAIN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 217 SPAIN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 218 SPAIN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 219 SPAIN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 220 SPAIN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 221 SPAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 222 SPAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 223 SPAIN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 224 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 225 SPAIN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 226 SPAIN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 227 SPAIN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 228 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 229 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 230 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 231 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 232 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 233 SWITZERLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 234 SWITZERLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 235 SWITZERLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 236 SWITZERLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 237 SWITZERLAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 238 SWITZERLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 239 SWITZERLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 240 SWITZERLAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 241 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 242 SWITZERLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 243 SWITZERLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 244 SWITZERLAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 245 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 246 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 247 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 248 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 249 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 250 NETHERLANDS AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 251 NETHERLANDS AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 252 NETHERLANDS PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 253 NETHERLANDS SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 254 NETHERLANDS LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 255 NETHERLANDS GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 256 NETHERLANDS GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 257 NETHERLANDS LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 258 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 259 NETHERLANDS PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 260 NETHERLANDS MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 261 NETHERLANDS UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 262 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 263 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 264 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 265 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 266 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 267 BELGIUM AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 268 BELGIUM AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 269 BELGIUM PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 270 BELGIUM SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 271 BELGIUM LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 272 BELGIUM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 273 BELGIUM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 274 BELGIUM LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 275 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 276 BELGIUM PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 277 BELGIUM MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 278 BELGIUM UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 279 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 280 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 281 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 282 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 283 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 284 DENMARK AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 285 DENMARK AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 286 DENMARK PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 287 DENMARK SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 288 DENMARK LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 289 DENMARK GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 290 DENMARK GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 291 DENMARK LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 292 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 293 DENMARK PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 294 DENMARK MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 295 DENMARK UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 296 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 297 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 298 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 299 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 300 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 301 RUSSIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 302 RUSSIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 303 RUSSIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 304 RUSSIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 305 RUSSIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 306 RUSSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 307 RUSSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 308 RUSSIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 309 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 310 RUSSIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 311 RUSSIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 312 RUSSIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 313 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 314 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 315 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 316 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 317 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 318 SWEDEN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 319 SWEDEN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 320 SWEDEN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 321 SWEDEN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 322 SWEDEN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 323 SWEDEN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 324 SWEDEN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 325 SWEDEN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 326 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 327 SWEDEN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 328 SWEDEN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 329 SWEDEN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 330 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 331 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 332 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 333 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 334 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 335 TURKEY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 336 TURKEY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 337 TURKEY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 338 TURKEY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 339 TURKEY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 340 TURKEY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 341 TURKEY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 342 TURKEY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 343 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 344 TURKEY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 345 TURKEY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 346 TURKEY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 347 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 348 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 349 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 350 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 351 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 352 POLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 353 POLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 354 POLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 355 POLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 356 POLAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 357 POLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 358 POLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 359 POLAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 360 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 361 POLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 362 POLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 363 POLAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 364 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 365 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 366 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 367 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 368 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 369 FINLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 370 FINLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 371 FINLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 372 FINLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 373 FINLAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 374 FINLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 375 FINLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 376 FINLAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 377 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 378 FINLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 379 FINLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 380 FINLAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 381 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 382 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 383 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 384 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 385 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 386 NORWAY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 387 NORWAY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 388 NORWAY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 389 NORWAY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 390 NORWAY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 391 NORWAY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 392 NORWAY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 393 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 394 NORWAY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 395 NORWAY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 396 NORWAY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 397 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 398 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 399 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 400 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 401 REST OF EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 402 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031 (USD THOUSAND)
TABLE 403 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 404 ASIA-PACIFIC AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 405 ASIA-PACIFIC AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 406 ASIA-PACIFIC PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 407 ASIA-PACIFIC SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 408 ASIA-PACIFIC LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 409 ASIA-PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 410 ASIA-PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 411 ASIA-PACIFIC LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 412 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 413 ASIA-PACIFIC PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 414 ASIA-PACIFIC MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 415 ASIA-PACIFIC UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 416 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 417 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 418 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 419 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 420 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 421 CHINA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 422 CHINA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 423 CHINA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 424 CHINA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 425 CHINA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 426 CHINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 427 CHINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 428 CHINA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 429 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 430 CHINA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 431 CHINA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 432 CHINA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 433 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 434 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 435 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 436 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 437 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 438 JAPAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 439 JAPAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 440 JAPAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 441 JAPAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 442 JAPAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 443 JAPAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 444 JAPAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 445 JAPAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 446 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 447 JAPAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 448 JAPAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 449 JAPAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 450 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 451 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 452 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 453 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 454 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 455 INDIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 456 INDIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 457 INDIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 458 INDIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 459 INDIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 460 INDIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 461 INDIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 462 INDIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 463 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 464 INDIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 465 INDIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 466 INDIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 467 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 468 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 469 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 470 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 471 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 472 AUSTRALIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 473 AUSTRALIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 474 AUSTRALIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 475 AUSTRALIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 476 AUSTRALIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 477 AUSTRALIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 478 AUSTRALIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 479 AUSTRALIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 480 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 481 AUSTRALIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 482 AUSTRALIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 483 AUSTRALIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 484 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 485 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 486 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 487 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 488 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 489 SOUTH KOREA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 490 SOUTH KOREA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 491 SOUTH KOREA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 492 SOUTH KOREA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 493 SOUTH KOREA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 494 SOUTH KOREA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 495 SOUTH KOREA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 496 SOUTH KOREA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 497 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 498 SOUTH KOREA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 499 SOUTH KOREA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 500 SOUTH KOREA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 501 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 502 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 503 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 504 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 505 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 506 THAILAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 507 THAILAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 508 THAILAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 509 THAILAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 510 THAILAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 511 THAILAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 512 THAILAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 513 THAILAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 514 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 515 THAILAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 516 THAILAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 517 THAILAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 518 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 519 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 520 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 521 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 522 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 523 SINGAPORE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 524 SINGAPORE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 525 SINGAPORE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 526 SINGAPORE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 527 SINGAPORE LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 528 SINGAPORE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 529 SINGAPORE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 530 SINGAPORE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 531 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 532 SINGAPORE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 533 SINGAPORE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 534 SINGAPORE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 535 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 536 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 537 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 538 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 539 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 540 INDONESIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 541 INDONESIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 542 INDONESIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 543 INDONESIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 544 INDONESIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 545 INDONESIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 546 INDONESIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 547 INDONESIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 548 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 549 INDONESIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 550 INDONESIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 551 INDONESIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 552 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 553 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 554 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 555 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 556 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 557 MALAYSIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 558 MALAYSIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 559 MALAYSIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 560 MALAYSIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 561 MALAYSIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 562 MALAYSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 563 MALAYSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 564 MALAYSIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 565 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 566 MALAYSIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 567 MALAYSIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 568 MALAYSIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 569 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 570 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 571 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 572 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 573 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 574 NEW ZEALAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 575 NEW ZEALAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 576 NEW ZEALAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 577 NEW ZEALAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 578 NEW ZEALAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 579 NEW ZEALAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 580 NEW ZEALAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 581 NEW ZEALAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 582 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 583 NEW ZEALAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 584 NEW ZEALAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 585 NEW ZEALAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 586 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 587 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 588 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 589 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 590 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 591 VIETNAM AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 592 VIETNAM AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 593 VIETNAM PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 594 VIETNAM SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 595 VIETNAM LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 596 VIETNAM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 597 VIETNAM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 598 VIETNAM LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 599 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 600 VIETNAM PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 601 VIETNAM MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 602 VIETNAM UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 603 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 604 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 605 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 606 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 607 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 608 PHILIPPINES AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 609 PHILIPPINES AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 610 PHILIPPINES PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 611 PHILIPPINES SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 612 PHILIPPINES LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 613 PHILIPPINES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 614 PHILIPPINES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 615 PHILIPPINES LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 616 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 617 PHILIPPINES PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 618 PHILIPPINES MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 619 PHILIPPINES UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 620 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 621 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 622 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 623 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 624 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 625 TAIWAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 626 TAIWAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 627 TAIWAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 628 TAIWAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 629 TAIWAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 630 TAIWAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 631 TAIWAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 632 TAIWAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 633 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 634 TAIWAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 635 TAIWAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 636 TAIWAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 637 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 638 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 639 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 640 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 641 REST OF ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 642 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031 (USD THOUSAND)
TABLE 643 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 644 SOUTH AMERICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 645 SOUTH AMERICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 646 SOUTH AMERICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 647 SOUTH AMERICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 648 SOUTH AMERICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 649 SOUTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 650 SOUTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 651 SOUTH AMERICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 652 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 653 SOUTH AMERICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 654 SOUTH AMERICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 655 SOUTH AMERICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 656 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 657 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 658 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 659 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 660 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 661 BRAZIL AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 662 BRAZIL AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 663 BRAZIL PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 664 BRAZIL SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 665 BRAZIL LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 666 BRAZIL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 667 BRAZIL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 668 BRAZIL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 669 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 670 BRAZIL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 671 BRAZIL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 672 BRAZIL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 673 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 674 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 675 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 676 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 677 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 678 ARGENTINA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 679 ARGENTINA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 680 ARGENTINA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 681 ARGENTINA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 682 ARGENTINA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 683 ARGENTINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 684 ARGENTINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 685 ARGENTINA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 686 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 687 ARGENTINA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 688 ARGENTINA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 689 ARGENTINA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 690 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 691 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 692 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 693 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 694 REST OF SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 695 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031(USD THOUSAND)
TABLE 696 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 697 MIDDLE EAST AND AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 698 MIDDLE EAST AND AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 699 MIDDLE EAST AND AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 700 MIDDLE EAST AND AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 701 MIDDLE EAST AND AFRICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 702 MIDDLE EAST AND AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 703 MIDDLE EAST AND AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 704 MIDDLE EAST AND AFRICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 705 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 706 MIDDLE EAST AND AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 707 MIDDLE EAST AND AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 708 MIDDLE EAST AND AFRICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 709 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 710 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 711 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 712 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 713 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 714 SOUTH AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 715 SOUTH AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 716 SOUTH AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 717 SOUTH AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 718 SOUTH AFRICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 719 SOUTH AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 720 SOUTH AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 721 SOUTH AFRICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 722 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 723 SOUTH AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 724 SOUTH AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 725 SOUTH AFRICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 726 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 727 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 728 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 729 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 730 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 731 SAUDI ARABIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 732 SAUDI ARABIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 733 SAUDI ARABIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 734 SAUDI ARABIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 735 SAUDI ARABIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 736 SAUDI ARABIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 737 SAUDI ARABIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 738 SAUDI ARABIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 739 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 740 SAUDI ARABIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 741 SAUDI ARABIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 742 SAUDI ARABIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 743 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 744 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 745 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 746 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 747 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 748 BAHRAIN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 749 BAHRAIN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 750 BAHRAIN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 751 BAHRAIN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 752 BAHRAIN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 753 BAHRAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 754 BAHRAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 755 BAHRAIN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 756 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 757 BAHRAIN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 758 BAHRAIN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 759 BAHRAIN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 760 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 761 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 762 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 763 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 764 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 765 UNITED ARAB EMIRATES AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 766 UNITED ARAB EMIRATES AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 767 UNITED ARAB EMIRATES PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 768 UNITED ARAB EMIRATES SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 769 UNITED ARAB EMIRATES LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 770 UNITED ARAB EMIRATES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 771 UNITED ARAB EMIRATES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 772 UNITED ARAB EMIRATES LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 773 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 774 UNITED ARAB EMIRATES PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 775 UNITED ARAB EMIRATES MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 776 UNITED ARAB EMIRATES UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 777 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 778 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 779 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 780 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 781 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 782 KUWAIT AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 783 KUWAIT AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 784 KUWAIT PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 785 KUWAIT SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 786 KUWAIT LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 787 KUWAIT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 788 KUWAIT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 789 KUWAIT LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 790 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 791 KUWAIT PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 792 KUWAIT MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 793 KUWAIT UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 794 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 795 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 796 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 797 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 798 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 799 QATAR AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 800 QATAR AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 801 QATAR PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 802 QATAR SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 803 QATAR LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 804 QATAR GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 805 QATAR GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 806 QATAR LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 807 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 808 QATAR PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 809 QATAR MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 810 QATAR UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 811 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 812 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 813 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 814 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 815 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 816 EGYPT AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 817 EGYPT AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 818 EGYPT PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 819 EGYPT SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 820 EGYPT LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 821 EGYPT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 822 EGYPT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 823 EGYPT LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 824 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 825 EGYPT PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 826 EGYPT MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 827 EGYPT UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 828 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 829 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 830 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 831 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 832 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 833 OMAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 834 OMAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 835 OMAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 836 OMAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 837 OMAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 838 OMAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 839 OMAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 840 OMAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 841 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 842 OMAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 843 OMAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 844 OMAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 845 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 846 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 847 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 848 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 849 REST OF MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
Список рисунков
FIGURE 1 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SEGMENTATION
FIGURE 2 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SEGMENTATION
FIGURE 9 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE THE FASTEST-GROWING REGION WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2031
FIGURE 10 A RISE IN THE INCIDENCE OF INBORN ERRORS OF METABOLISM AND AN INCREASE IN THE NUMBER OF THE NEWBORN SCREENING PROCEDURES ARE EXPECTED TO DRIVE THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2031
FIGURE 11 THE AMINO ACID SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET IN 2023 AND 2031
FIGURE 12 ASIA-PACIFIC IS THE MAXIMUM GROWING REGION FOR THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2031
FIGURE 13 EPIDEMIOLOGY
FIGURE 14 PORTER’S FIVE FORCES
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET
FIGURE 16 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS, 2022
FIGURE 17 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISEASES, 2022
FIGURE 18 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY AGE GROUP, 2022
FIGURE 19 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY FORMS, 2022
FIGURE 20 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PACKAGING, 2022
FIGURE 21 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 22 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2022)
FIGURE 23 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2022)
FIGURE 24 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET : SNAPSHOT (2022)
FIGURE 25 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET:SNAPSHOT (2022)
FIGURE 26 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET:SNAPSHOT (2022)
FIGURE 27 MIDDLE EAST AND AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET:SNAPSHOT (2022)
FIGURE 28 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2023 (%)
FIGURE 29 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2023 (%)
FIGURE 30 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2023 (%)
FIGURE 31 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2023 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.